Triangle-based Continuous Precision Medicine developed a mobile app to track pain management and prescription medication ...

A new study finds the genetic backgrounds of people in the U.S. are "highly complex" and may differ from their self-defined ...

Danaher Corporation DHR recently partnered with AstraZeneca PLC AZN to develop and market novel diagnostic tools aimed at ...

The conversation centred on the company’s latest developments and strategic direction in cancer therapies, with a particular ...

As National Cancer Survivors Month begins, survivors and medical professionals are highlighting the impact of personalized ...

- Scientific Advisory Board brings together distinguished experts in neuroscience to support Denovo's CNS development programs, including the Phase 3-ready lead program, biomarker-guided DB104 ...

Advances have made cancer therapies more effective through targeting specific molecules. Companion diagnostics (CDx) are ...

Radiopharmaceuticals are transforming modern medicine, while simultaneously intensifying the pressures on pharmaceutical ...

Shares of Tempus AI ( TEM 14.71%) soared on Monday. The company's stock jumped 15% as of market close. The spike comes as the ...

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - ...

Researchers at Western Sydney University have developed an AI-powered tool that uses dynamic risk scores based on blood ...